5,909 results match your criteria: "Primitive Neuroectodermal Tumors of the Central Nervous System"

Background: Cytokine-induced killer (CIK) cell therapy has proven successful in clinical trials regarding glioblastoma. Equally important are the hints suggesting peroxisome proliferator-activated receptors (PPARs) ligands being co-expressed in the central nervous system (CNS). This provides a rationale about investigating the possible synergistic effect of CIK cells and PPARs.

View Article and Find Full Text PDF
Article Synopsis
  • * A 17-year-old male presented with headaches and walking difficulties, leading to the discovery of a CPA lesion, which was surgically removed and diagnosed as medulloblastoma; he then received chemo-radiotherapy.
  • * After two years, the patient experienced new headaches and seizures, resulting in the identification of a metastatic tumor in the temporal lobe, also confirmed as medulloblastoma.
View Article and Find Full Text PDF

Differential Replication and Oncolytic Effects of Zika Virus in Aggressive CNS Tumor Cells: Insights from Organoid and Tumoroid Models.

Viruses

November 2024

Human Genome and Stem Cell Research Center (CEGH-CEL), Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, Cidade Universitária, São Paulo 05508-090, SP, Brazil.

Article Synopsis
  • CNS cancers like Glioblastoma and pediatric tumors face significant treatment challenges due to their poor response to conventional therapies such as radiation and chemotherapy.* -
  • Recent research highlights the potential of the Zika virus (ZIKV) as an oncolytic treatment, showing its ability to infect and kill malignant CNS tumor cells while having a preference for tumor rather than normal cells.* -
  • Experiments using hybrid co-culture models demonstrated that ZIKV replication was enhanced in tumor cells compared to normal cells, leading to notable reductions in the number of certain tumor types, although not uniformly effective across all cancers.*
View Article and Find Full Text PDF

The central nervous system (CNS) involves a complex interplay of communications between the neurons and various glial cells, which is crucial for brain functions. The major interactomes are exosomes that transmit sundry molecules (DNA, miRNAs, and proteins) between the cells and thus alter cell physiology. Exosomes can act as neuroprotective or neurodegenerative agents depending on the microenvironment of cells secreting them.

View Article and Find Full Text PDF

The Abnormal Proliferation of Midbrain Dopamine Cells From Human Pluripotent Stem Cells Is Induced by Exposure to the Tumor Microenvironment.

CNS Neurosci Ther

November 2024

Department of Neurosurgery, Huashan Hospital, MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.

Article Synopsis
  • The study addresses the issue of tumorigenicity in stem cell therapies, highlighting the need for more accurate testing methods beyond traditional animal models.
  • Researchers exposed midbrain dopamine (mDA) cells from human pluripotent stem cells to a tumor microenvironment by coculturing with medulloblastoma, observing increased proliferation in both lab and living models.
  • Findings suggest that this abnormal proliferation is linked to the activation of specific genetic pathways and cytokines, indicating that such exposure can improve tumorigenicity assessment methods.
View Article and Find Full Text PDF
Article Synopsis
  • Brain tumors are the leading cause of cancer-related deaths in children, with medulloblastoma (MB) being the most prevalent type, exhibiting strong invasion and rapid spread.
  • In 2010, the World Health Organization categorized MB into four distinct molecular subtypes (WNT, SHH, Group 3, and Group 4), each having unique characteristics and varying prognoses.
  • Metabolomics, a sophisticated analytical technique, holds promise for personalized medicine by analyzing metabolites to better understand MB and develop targeted treatment strategies.
View Article and Find Full Text PDF

Overcoming the limits of pediatric brain tumor radiotherapy: The use of preclinical 3D models.

Cancer Radiother

October 2024

Radiobiology Laboratory, institut de cancérologie Strasbourg Europe (ICANS), 3, rue de la Porte-de-l'Hôpital, 67000 Strasbourg, France; Laboratory of Engineering, Informatics and Imaging (ICube), Integrative multimodal imaging in healthcare (Imis), UMR 7357, université de Strasbourg, 4, rue Kirschleger, 67000 Strasbourg, France. Electronic address:

Radiotherapy (RT) is an integral part of managing pediatric brain tumors, yet many patients develop tumor radioresistance, leading to recurrence and poor clinical outcomes. In addition, neurocognitive impairment is a common long-term side effect of RT, significantly impairing quality of life. Indeed, increasing evidence suggests that the developing child's brain is particularly vulnerable to the neurotoxic effects of ionizing radiation.

View Article and Find Full Text PDF

Xenotransplantation of neuroblastoma cells into larval zebrafish allows the characterization of their tumorigenic abilities and high-throughput treatment screening. This established preclinical model traditionally relies on microinjection into the yolk or perivitelline space, leaving the engraftment ability of cells at the hindbrain ventricle (HBV) and pericardial space (PCS), sites valuable for evaluating metastasis, angiogenesis, and the brain microenvironment, unknown. To address this gap in knowledge, Casper zebrafish at 48 h postfertilization were microinjected with approximately 200 Kelly, Be(2)-C, SK-N-AS, or SY5Y cells into either the HBV or PCS.

View Article and Find Full Text PDF
Article Synopsis
  • Primary central nervous system tumors rank as the second most common cancer in children in high-income countries, but there is limited research on this issue in low- and middle-income countries.
  • This study focused on the disparities in detection, treatment, and survival rates of children with these tumors, using a case series of three medulloblastoma patients in Uganda.
  • The findings indicate significant differences in care quality, with challenges in Uganda including a lack of specialist access, long distances to treatment centers, and issues with accurate diagnosis.
View Article and Find Full Text PDF
Article Synopsis
  • Direct administration of chemotherapy into the fourth ventricle is a new method aimed at treating kids with recurrent malignant brain tumors in the posterior fossa.
  • The chapter reviews the reasoning behind this drug infusion strategy, shares results from animal studies that showed it is safe and effective, and highlights its promising impact on human trials.
  • It also outlines ongoing clinical trials testing different drugs for this treatment and suggests future research directions for improving outcomes.
View Article and Find Full Text PDF

Recent investigations indicate that tannic acid is associated with a decrease in oxidative damage. Growing evidence supports the protective effects of tannic acid on the central nervous system (CNS). However, uncertainties persist regarding its influence on hydrogen peroxide (HO)-triggered oxidative impairment in nerve cells and its interaction with apoptosis.

View Article and Find Full Text PDF

Background: Treatment for dural recurrence of olfactory neuroblastoma (ONB) is not standardized. We assess the outcomes of stereotactic body radiotherapy (SBRT) in this population.

Methods: ONB patients with dural recurrences treated between 2013 and 2022 on a prospective registry were included.

View Article and Find Full Text PDF
Article Synopsis
  • * A case study detailed a 23-year-old female with a large tumor in her right frontal region that appeared similar to a meningioma, but histopathology revealed it was actually a supratentorial neuroblastoma.
  • * Accurate diagnosis of PCN-NB is challenging due to inconsistent imaging, which highlights the necessity of histopathological examination for proper identification of these tumors in patients with extra-axial lesions.
View Article and Find Full Text PDF

Medulloblastoma subgrouping at first sight.

Cancer Cell

July 2024

Division of Haematology/Oncology, Developmental and Stem Cell Biology Program, Hospital for Sick Children, Toronto, ON, Canada; Departments of Medical Biophysics and Paediatrics, University of Toronto, Toronto, ON, Canada. Electronic address:

Article Synopsis
View Article and Find Full Text PDF

Early rhombic lip Protogenin stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma.

Cell

August 2024

The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Texas Children's Cancer and Hematology Center, Houston, TX, USA; Department of Pediatrics - Hematology/Oncology, Baylor College of Medicine, Houston, TX, USA; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA; Department of Neurosurgery, Texas Children's Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA; Department of Surgery, University of Toronto, Toronto, ON, Canada. Electronic address:

Article Synopsis
View Article and Find Full Text PDF

Medulloblastoma is a malignant neuroepithelial tumor of the central nervous system. Accurate prediction of prognosis is essential for therapeutic decisions in medulloblastoma patients. We analyzed data from 2,322 medulloblastoma patients using the SEER database and randomly divided the dataset into training and testing datasets in a 7:3 ratio.

View Article and Find Full Text PDF

Background And Purpose: Hemangioblastoma is a rare vascular tumor that occurs within the central nervous system in children. Differentiating hemangioblastoma from other posterior fossa tumors can be challenging on imaging, and preoperative diagnosis can change the neurosurgical approach. We hypothesize that a "lightbulb sign" on the arterial spin-labeling (ASL) sequence (diffuse homogeneous intense hyperperfusion within the solid component of the tumor) will provide additional imaging finding to differentiate hemangioblastoma from other posterior fossa tumors.

View Article and Find Full Text PDF